Voglibite-GM 2 Tablet SR
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglibite-GM 2 Tablet SR
DiaGlyce-Duo 2mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation is indicated for adult patients with type 2 diabetes mellitus to manage glycemic control. Optimal blood sugar regulation is achieved through consistent daily dosing, always taken with food, at the same time each day. Dosage adjustments are determined by your physician based on your individual response and blood glucose readings. Continued use, even with well-managed blood sugar, is crucial. Discontinuation without medical supervision risks elevated blood glucose, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb ischemia. This medication is a component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms such as sweating, lightheadedness, cephalgia, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals should seek medical advice before commencing therapy. Regular blood glucose monitoring is necessary; additional blood tests to evaluate hematologic parameters and liver function may be recommended by your doctor.
Uses of Voglibite-GM 2 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglibite-GM 2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglibite-GM 2 Tablet SR should be administered on an empty stomach.
Common Side effects of Voglibite-GM 2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglibite-GM 2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglibite-GM 2 Tablet SR on an empty stomach.
How Voglibite-GM 2 Tablet SR works:
Voglibite-GM 2 sustained-release tablets contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglibite-GM 2 Tablet SR with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Voglibite-GM 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Voglibite-GM 2 Tablet formulation likely poses a risk during lactation. Available human data indicate potential transfer to breast milk, with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Voglibite-GM 2 Tablet SR is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglibite-GM 2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Initial dosing of Voglibite-GM 2 Tablet SR is typically low for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Voglibite-GM 2 Tablet SR :
Should you forget a Voglibite-GM 2 Tablet SR dose, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Voglibite-GM 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





